s6y
Company name or ticker
Search
Halstead Michael
4
Intra-Cellular Therapies, Inc.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, January 11, 2022
Period
Jan 8, 2022
Accession number
0001209191-22-002989
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header